From Monday, 4 November to Wednesday, 6 November, AmCham EU visited Copenhagen, Denmark to engage with Danish officials and discuss the latest life science developments. The delegates met with representatives from a range of government institutions, including the Ministry of Business, the Ministry of Industry and the Ministry of the Interior and Health. Top of mind throughout the visit was the potential revision of the Medical Devices Regulation, the Critical Medicines Act and the EU Pharmaceutical Legislation. With the EU being the world’s largest exporter of medicines in 2023, learn why reliable global life sciences supply chains are fundamental to resilient health systems.
Discussing healthcare developments in Copenhagen

Related items
:focal())
Statement on Section 301 investigations
On Wednesday, 11 March, the United States Trade Representative launched Section 301 investigations into structural production overcapacity against a range of economies, including the European Union. We understand that this decision is part of a larger attempt to stabilise the US tariff system in the wake of the Supreme Court ruling striking down the International Emergency Economic Powers Act (IEEPA) tariffs.
The American Chamber of Commerce to the European Union (AmCham EU) is concerned about the continued uncertainty of the current trade environment. Companies still lack clarity over future tariff rates in both the short- and long-term. We continue to oppose broad-based tariffs as they raise costs for businesses and consumers and disrupt supply chains.
With potential measures against the EU under consideration, AmCham EU calls on the EU and the US to avoid escalation in the trade dispute. The priority must be to restore stability and predictability in transatlantic trade. The deal struck in the summer is not a perfect solution, but it offers the most realistic path forward given political priorities on both sides. We look to the parties to honour their commitments under the EU-US Framework Agreement.
The US Administration rightfully identifies overcapacity as a critical issue in the global economy which also affects the European market. We see the EU as part of the solution, rather than the problem. The EU and the US must work together to tackle the real issue at hand: unfair trading practices from non-market economies.
:focal())
Advancing EU data and cybersecurity rules through the Digital Omnibus
:focal())
Supporting artificial intelligence uptake through the AI Omnibus
Policy priorities
Insights and advocacy driving Europe’s policy agenda. Our priorities support growth, innovation and a stronger transatlantic economy.
Membership
Connecting business and policymakers to strengthen the voice of American companies in Europe.